Allergy Asthma Immunol Res.  2010 Oct;2(4):267-270. 10.4168/aair.2010.2.4.267.

A Case of Recurrent Toxocariasis Presenting With Urticaria

Affiliations
  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. addchang@snu.ac.kr
  • 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea.
  • 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Abstract

Human toxocariasis is the most prevalent helminthiasis in Korea and other industrialized countries. The clinical features of toxocariasis are diverse, according to the involved organ. Typically, Toxocara spp. infection is easily treated with 400 mg albendazole twice a day for 5 days. However, we experienced a case of recurrent toxocariasis that was refractory to this standard therapy and presented with urticaria, an uncommon symptom in toxocariasis. A 35-year-old male visited our emergency room because of abdominal pain. He had recently consumed raw cow liver (3 weeks prior to presentation). Laboratory analyses revealed eosinophilia (1,612 cells/microliter) and increased total IgE (3,060 IU/mL). Chest X-ray showed multiple lung nodules in both lungs, and computed tomography revealed multiple ground-glass opacities in both lungs and multiple tiny liver abscesses. Liver biopsy revealed an eosinophilic abscess. Enzyme-linked immunosorbent assay findings for Toxocara antigens were positive (optical density, 2.140), leading to a diagnosis of toxocariasis. We initiated a 5-day treatment with albendazole and prednisolone; however, 6 days after completing the treatment, the patient again experienced urticaria and severe itching that could not be controlled by antihistamines or hydrocortisone cream. A second bout of eosinophilia suggested recurring toxocariasis, for which we prescribed a second round of albendazole. Despite an initial improvement in his symptoms, the patient returned after 6 weeks complaining of abdominal pain for 6 hours, which was reminiscent of his first attack; he also exhibited eosinophilia. Accordingly, albendazole was administered once more for an additional 3 weeks, and his symptoms resolved.

Keyword

Abdominal pain; albendazole; toxocariasis; urticaria

MeSH Terms

Abdominal Pain
Abscess
Adult
Albendazole
Biopsy
Developed Countries
Emergencies
Enzyme-Linked Immunosorbent Assay
Eosinophilia
Eosinophils
Helminthiasis
Histamine Antagonists
Humans
Hydrocortisone
Immunoglobulin E
Korea
Liver
Liver Abscess
Lung
Male
Pruritus
Thorax
Toxocara
Toxocariasis
Urticaria
Albendazole
Histamine Antagonists
Hydrocortisone
Immunoglobulin E

Figure

  • Fig. 1 Multiple tiny liver abscesses in abdomen CT.

  • Fig. 2 Multiple ground-glass opacities in both lungs in chest CT.

  • Fig. 3 Patchy and dense eosinophilic infiltration in liver biopsy (H&E stain, A: ×200, B: ×400).

  • Fig. 4 Serial change of eosinophil count according to recurrence.


Cited by  1 articles

Recent Advances in the Use of Anthelmintics for Treating Nematode Infections
Jong-Yil Chai
Infect Chemother. 2011;43(1):26-35.    doi: 10.3947/ic.2011.43.1.26.


Reference

1. Magnaval JF, Glickman LT, Dorchies P, Morassin B. Highlights of human toxocariasis. Korean J Parasitol. 2001; 39:1–11.
2. Park HY, Lee SU, Huh S, Kong Y, Magnaval JF. A seroepidemiological survey for toxocariasis in apparently healthy residents in Gangwon-do, Korea. Korean J Parasitol. 2002; 40:113–117.
3. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003; 16:265–272.
4. Choi D, Lim JH, Choi DC, Paik SW, Kim SH, Huh S. Toxocariasis and ingestion of raw cow liver in patients with eosinophilia. Korean J Parasitol. 2008; 46:139–143.
5. Gavignet B, Piarroux R, Aubin F, Millon L, Humbert P. Cutaneous manifestations of human toxocariasis. J Am Acad Dermatol. 2008; 59:1031–1042.
6. Humbert P, Niezborala M, Salembier R, Aubin F, Piarroux R, Buchet S, Barale T. Skin manifestations associated with toxocariasis: a case-control study. Dermatology. 2000; 201:230–234.
7. Yoshikawa M. Duration of treatment with albendazole for hepatic toxocariasis. Nat Clin Pract Gastroenterol Hepatol. 2009; 6:E1–E2.
8. Stürchler D, Schubarth P, Gualzata M, Gottstein B, Oettli A. Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. Ann Trop Med Parasitol. 1989; 83:473–478.
9. Takamatsu K, Sumitani M, Nanjyou S, Nishijima M, Syoji S, Takifuji N, Kiyota H, Daga H, Takeda K. Case of Toxocara canis larva migrans cured by additional treatment with albendazole. Nihon Kokyuki Gakkai Zasshi. 2008; 46:836–841.
Full Text Links
  • AAIR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr